One study conducted on breast cancer cell line showed that extracellular treatments with S100A8 and S100A9 proteins induce cell proliferation, while intracellular recombinant expression of S100A8 and S100A9 block cancer cells grow. Here, S100A9 is linked to breast carcinoma.